Netanel A. Horowitz

2.9k total citations
77 papers, 1.0k citations indexed

About

Netanel A. Horowitz is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Netanel A. Horowitz has authored 77 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 24 papers in Pathology and Forensic Medicine and 24 papers in Hematology. Recurrent topics in Netanel A. Horowitz's work include Lymphoma Diagnosis and Treatment (24 papers), Acute Lymphoblastic Leukemia research (12 papers) and CNS Lymphoma Diagnosis and Treatment (11 papers). Netanel A. Horowitz is often cited by papers focused on Lymphoma Diagnosis and Treatment (24 papers), Acute Lymphoblastic Leukemia research (12 papers) and CNS Lymphoma Diagnosis and Treatment (11 papers). Netanel A. Horowitz collaborates with scholars based in Israel, United States and United Kingdom. Netanel A. Horowitz's co-authors include Benjamin Brenner, Irit Avivi, Noa Lavi, Joseph S. Palumbo, Noam Benyamini, Kathryn E. Talmage, Jacob M. Rowe, Matthew J. Flick, Israel Henig and Fred D. Finkelman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Netanel A. Horowitz

67 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Netanel A. Horowitz Israel 17 429 229 215 176 154 77 1.0k
James N. Butera United States 20 638 1.5× 545 2.4× 172 0.8× 129 0.7× 165 1.1× 55 1.2k
Lidia Gil Poland 17 413 1.0× 192 0.8× 414 1.9× 170 1.0× 269 1.7× 136 1.2k
Martin Mohren Germany 17 188 0.4× 185 0.8× 321 1.5× 98 0.6× 170 1.1× 37 936
Esteban Abella United States 17 512 1.2× 225 1.0× 551 2.6× 178 1.0× 155 1.0× 56 1.3k
Federica Sorà Italy 18 296 0.7× 110 0.5× 513 2.4× 208 1.2× 227 1.5× 95 1.2k
Jeanne Odom United States 13 412 1.0× 210 0.9× 364 1.7× 95 0.5× 91 0.6× 27 1.1k
Panagiotis Tsirigotis Greece 22 445 1.0× 176 0.8× 767 3.6× 199 1.1× 251 1.6× 122 1.6k
Satish Shanbhag United States 14 278 0.6× 219 1.0× 337 1.6× 81 0.5× 190 1.2× 37 931
Matthew D. Seftel Canada 24 524 1.2× 326 1.4× 741 3.4× 225 1.3× 289 1.9× 111 1.6k
Kimikazu Yakushijin Japan 19 278 0.6× 151 0.7× 561 2.6× 215 1.2× 146 0.9× 135 1.1k

Countries citing papers authored by Netanel A. Horowitz

Since Specialization
Citations

This map shows the geographic impact of Netanel A. Horowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Netanel A. Horowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Netanel A. Horowitz more than expected).

Fields of papers citing papers by Netanel A. Horowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Netanel A. Horowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Netanel A. Horowitz. The network helps show where Netanel A. Horowitz may publish in the future.

Co-authorship network of co-authors of Netanel A. Horowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Netanel A. Horowitz. A scholar is included among the top collaborators of Netanel A. Horowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Netanel A. Horowitz. Netanel A. Horowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gurion, Ronit, Meirav Kedmi, Chava Perry, et al.. (2025). Efficacy and safety of Glofitamab in patients with R/R DLBCL in real life setting– a retrospective study. Annals of Hematology. 104(7). 3821–3827.
2.
Horowitz, Netanel A., et al.. (2025). Novel therapies for acute myeloid leukemia. Does age still matter?. Blood Reviews. 74. 101317–101317.
3.
Kedmi, Meirav, Ohad Benjamini, Ginette Schiby, et al.. (2024). Ibrutinib With Bendamustine and Rituximab for Treatment of Patients With Relapsed/Refractory Aggressive B‐Cell Lymphoma. Hematological Oncology. 42(6). e70001–e70001.
4.
5.
Vainstein, Vladimir, Batia Avni, Sigal Grisariu, et al.. (2023). Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?. Cancers. 15(13). 3471–3471. 8 indexed citations
6.
Bairey, Osnat, Alexandra Amiel, Shlomit Yust‐Katz, et al.. (2023). A phase 2 study of ibrutinib maintenance following first‐line high‐dose methotrexate‐based chemotherapy for elderly patients with primary central nervous system lymphoma. Cancer. 129(24). 3905–3914. 13 indexed citations
7.
Brenner, Benjamin, et al.. (2022). Thrombosis in Pregnant Women with Hematological Malignancies: A Case-Based Review. Seminars in Thrombosis and Hemostasis. 49(4). 348–354.
8.
Shargian, Liat, Odelia Amit, Hanna Bernstine, et al.. (2022). The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission—A retrospective multicenter study. European Journal Of Haematology. 110(2). 149–156. 2 indexed citations
9.
Braun, Eyal, Netanel A. Horowitz, Ronit Leiba, et al.. (2022). Association between IgG antibody levels and adverse events after first and second Bnt162b2 mRNA vaccine doses. Clinical Microbiology and Infection. 28(12). 1644–1648. 6 indexed citations
10.
Glinert, Itai, Amir Ben‐Shmuel, Adi Beth-Din, et al.. (2022). Revisiting SARS-CoV-2 environmental contamination by patients with COVID-19: The Omicron variant does not differ from previous strains. International Journal of Infectious Diseases. 118. 211–213. 6 indexed citations
11.
Eisenkraft, Arik, ‪Yasmin Maor‬‏, Keren Constantini, et al.. (2021). Continuous Remote Patient Monitoring Shows Early Cardiovascular Changes in COVID-19 Patients. Journal of Clinical Medicine. 10(18). 4218–4218. 12 indexed citations
12.
Azoulay, David & Netanel A. Horowitz. (2021). Brain-derived neurotrophic factor in hematological malignancies: From detrimental to potentially beneficial. Blood Reviews. 51. 100871–100871. 5 indexed citations
13.
Zuckerman, Tsila, Ron Ram, Luiza Akria, et al.. (2019). BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study. Blood Advances. 3(22). 3740–3749. 10 indexed citations
14.
15.
Weissmann, Marina, Gil Arvatz, Netanel A. Horowitz, et al.. (2016). Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis. Proceedings of the National Academy of Sciences. 113(3). 704–709. 89 indexed citations
16.
Ganzel, Chezi, Ory Rouvio, Hila Magen, et al.. (2016). Primary Plasma Cell Leukemia Has a Poor Prognosis Even in the Era of Novel Agents - a Multicenter Case Series. Blood. 128(22). 5699–5699. 1 indexed citations
17.
Horowitz, Netanel A., Noa Lavi, Yona Nadir, & Benjamin Brenner. (2016). Haematological malignancies in pregnancy: An overview with an emphasis on thrombotic risks. Thrombosis and Haemostasis. 116(10). 613–617. 15 indexed citations
18.
19.
Horowitz, Netanel A., et al.. (2014). Does Gender Matter in Non-Hodgkin Lymphoma? Differences in Epidemiology, Clinical Behavior, and Therapy. Rambam Maimonides Medical Journal. 5(4). e0038–e0038. 50 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James N. Butera Breakdown of academic impact, for papers by Lidia Gil Breakdown of academic impact, for papers by Martin Mohren Breakdown of academic impact, for papers by Esteban Abella Breakdown of academic impact, for papers by Federica Sorà Breakdown of academic impact, for papers by Jeanne Odom Breakdown of academic impact, for papers by Panagiotis Tsirigotis Breakdown of academic impact, for papers by Satish Shanbhag Breakdown of academic impact, for papers by Matthew D. Seftel Breakdown of academic impact, for papers by Kimikazu Yakushijin
Rankless by CCL
2026